Clinical trial
The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome
NCT05874830 is registered in ClinicalTrials.gov with Turku University Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Optimal Route of Fecal Microbiota Transplantation for Irritable Bowel Syndrome
- Lead sponsor
- Turku University Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 15, 2021
- Completion date
- December 1, 2025
- Enrollment
- 36 (estimated)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
ibs - irritable bowel syndrome, microbial substitution